Skip to main content

Clinical Relevance of Cytokine Levels in Blood Products: Evidence to Correlate with Morbidity

  • Chapter

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 32))

Abstract

Complications associated with the infusion of blood and blood products are not uncommon. They can present as acute reactions occurring during, or within a few hours of the transfusion, or as delayed events, presenting days or possibly years later (Table 1). Patient morbidity is variable depending on the type of reaction and with some reactions mortality can occur [1,2].

This manuscript was supported in part by grants from the Miles-CRC Research Fund and the Medical Research Council of Canada.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heddle NM. Noninfectious adverse reactions to blood transfusion. In: Current Therapy In Haematology-Oncology. Brain MC, Carbone PP, eds, Mosby-YearBook Inc., St. Louis, MI, 1995:p225–30.

    Google Scholar 

  2. AABB Annual Meeting Serminar. In: Transfusion-Transmitted Viral Diseases, Moore SB (ed) American Association of Blood Banks, Arlington, VA, 1987.

    Google Scholar 

  3. Davenport RD, Kunkel SL. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transf Med Rev 1994;VIII: 157–68.

    Article  Google Scholar 

  4. Muylle L, Joos M, Wouters E, de Bock R, Peetermans ME. Increased tumour necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195–99.

    Article  PubMed  CAS  Google Scholar 

  5. Silliman C, Thurman G, Ambruso D. Agents that prime the neutrophil (PMN) oxidase develop during routine storage of platelet concentrates. Blood 1992;80:365a.

    Google Scholar 

  6. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20–25.

    Article  PubMed  CAS  Google Scholar 

  7. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117–24.

    Article  PubMed  CAS  Google Scholar 

  8. Schleuning M, Bock M, Mempel W. Complement activation during storage of single-donor platelet concentrates. Vox Sang 1994;67:144–48.

    Article  PubMed  CAS  Google Scholar 

  9. Heddle NM, Klama L, Singer J, et al. The role of the plasma supernatant from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625–28.

    Article  PubMed  CAS  Google Scholar 

  10. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14–17.

    Article  PubMed  CAS  Google Scholar 

  11. Kluter H, Müller-Steinhardt M, Danzer S, Wilhelm D, Kirchner H. Cytokines in platelet concentrates prepared from pooled buffy coats. Vox Sang 1995;69:38–43.

    Article  PubMed  CAS  Google Scholar 

  12. Miletic VD, Popovic O. Complement activation in stored platelet concentrates. Transfusion 1993;33:150–54.

    Article  PubMed  CAS  Google Scholar 

  13. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124:684–94.

    PubMed  CAS  Google Scholar 

  14. Snyder EL. Removal of complement chemokines and other soluble biological response modifiers, by Pall bedside leukoreduction and plasma filter. Bloodlink, Pall Biomedical Products Company, Vol. 4, 1995.

    Google Scholar 

  15. Snyder EL, Stack G. Febrile and nonimmune transfusion reactions. In: Rossi EC, Simon TL, Moss GS, eds. Principles of transfusion medicine. Baltimore: Williams & Wilkins, 1996:641–60.

    Google Scholar 

  16. Decary F, Ferner P, Giavedoni L, et al. An investigation of nonhaemolytic transfusion reactions. Vox Sang 1984;46:277–85.

    Article  PubMed  CAS  Google Scholar 

  17. Heddle NM, Klama L, Ball S, Tan MK, Christmas T. The effect of blood product preparation on cytokine levels. Transfusion 1996;36(Suppl):15.

    Google Scholar 

  18. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88: 1362–69.

    Article  PubMed  CAS  Google Scholar 

  19. Heddle N, Tan M, Klama L, Shroeder J. Factors affecting cytokine production in platelet concentrates. Transfusion 1994;34:67S.

    Google Scholar 

  20. Frewin DB, Jonsson JR, Head RJ, Russell WJ, Beal RW. Histamine levels in stored human blood. Transfusion 1984;24:502–04.

    Article  PubMed  CAS  Google Scholar 

  21. Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston, MA, Little, Brown, 1985.

    Google Scholar 

  22. Guyatt GH, Sackett DL, Cook DJ. Evidence-based medicine: User’s guide to the medical literature. II. How to use an article about therapy or prevention. Part A. Are the results of the study valid? JAMA 1994;271:59–63.

    Article  PubMed  CAS  Google Scholar 

  23. Guyatt GH, Sackett DL, Cook DJ. Evidence-based medicine: User’s guide to the medical literature. II. How to use an article about therapy or prevention. Part B. What are the results and will they help me in caring for my patients? JAMA 1993;270: 2598–601

    Article  PubMed  CAS  Google Scholar 

  24. Walker RH, ed. Technical manual. 10th ed. Arlington: American Association of Blood Banks, 1990:420.

    Google Scholar 

  25. Payne R. The association of febrile transfusion reactions with leuko-agglutinins. Vox Sang 1957;2:233–41.

    Article  PubMed  CAS  Google Scholar 

  26. Payne R, Rolfs MR. Further observations on leukoagglutinin transfusion reactions. With special reference to leukoagglutinin transfusion reactions in women. Am J Med 1960;30:449–58.

    Article  Google Scholar 

  27. Perkins HA, Payne R, Ferguson J, Wood M. Nonhaemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 1966;11:578–600.

    Article  PubMed  CAS  Google Scholar 

  28. Menitove JE, McElligott MC, Aster RH. Febrile transfusion reaction: what blood component should be given next? Vox Sang 1982;41:318–21.

    Article  Google Scholar 

  29. Chambers LA, Kruskall MS, Pacini DG, Donovan LM. Febrile reactions after platelet transfusion: the effect of single versus multiple donors. Transfusion 1990;30:219–21.

    Article  PubMed  CAS  Google Scholar 

  30. Mangano MM, Chambers LA, Kruskall MS. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 1991;95:733–38.

    PubMed  CAS  Google Scholar 

  31. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794–97.

    Article  PubMed  CAS  Google Scholar 

  32. Muylle L, Wouters E, de Bock R, Peetermans ME. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med 1992;2:289–93.

    Article  PubMed  CAS  Google Scholar 

  33. Muylle L. Ex vivo Cytokine Production in Blood Components: Relevant or Irrelevant. Kluwer Academic Publishers: London, Vol 32, 1994.

    Google Scholar 

  34. Heddle NM, Kelton JG. Febrile non-haemolytic transfusion reactions. AABB Press 1996.

    Google Scholar 

  35. Shimizu T, Uchigiri C, Mizuno S, Kamiya T, Kokubo Y. Adsorption of anaphylatoxins and platelet-specific proteins by filtration of platelet concentrates with a polyester leukocyte reduction filter. Vox Sang 1994;66:161–65.

    Article  PubMed  CAS  Google Scholar 

  36. Snyder E, Napychank P, Baril L. Removal of complement component C3a and inter-leukin-8 from platelet concentrate by a bedside leukodepletion filter. Transfusion 1994; 34(Suppl):31S.

    Google Scholar 

  37. Whitebread J, Besso N, Onunka V, Brandwein H. Reduction of C3A fragment levels following leukodepletion using a Pall PXL8 filter. Transfusion 1994;84:672a.

    Google Scholar 

  38. Hed J, Johansson M, Lindroth M. Complement activation according to the alternate pathway by glass and plastic surfaces and its role in neutrophil adhesion. Immunology Letters 1984;8:295–99.

    Article  PubMed  CAS  Google Scholar 

  39. Sevast’ianov VI, Tseytlina EA. The activation of the complement system by polymer materials and their blood compatibility. J Biomed Res 1984;18:969–78.

    Article  Google Scholar 

  40. Oksanen K, Ebeling F, Kekomäki R, et al. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 1994;67: 356–61.

    Article  PubMed  CAS  Google Scholar 

  41. Anderson KC, Gorgone BC, Wahlers E, Cook J, Barrett B, Andersen J. Preparation and clinical utility of leukocyte poor apheresis platelets. Transfus Sci 1991;12:163–70.

    Article  Google Scholar 

  42. Dzieczkowski JS, Barrett BB, Nester D, et al. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 1995;35: 20–5.

    Article  PubMed  CAS  Google Scholar 

  43. Federowicz I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996;36:21–28.

    Article  PubMed  CAS  Google Scholar 

  44. Muir JC, Jacobson S, Herschel L, AuBuchon JP. Does pre-storage leukocyte reduction of blood components reduce the risk of febrile reactions in sensitized patients? Blood 1994;84(Suppl):1842.

    Google Scholar 

  45. Muir JC, Herschel L, Pickard C, auBuchon JP. Pre-storage leukocyte reduction decreases the risk of febrile reactions in sensitized platelet recipients. Transfusion 1995; 35(Suppl):45S.

    Google Scholar 

  46. Sacher RA. High circulating interleukin 6 levels associated with acute transfusion reaction: cause or effect? Transfusion 1993;33:962(letter).

    Google Scholar 

  47. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of haemotherapy. Transfusion 1992;32:589–92.

    Article  PubMed  CAS  Google Scholar 

  48. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–77.

    Article  PubMed  CAS  Google Scholar 

  49. Rot A. Some aspects of NAP-1 pathophysiology: lung damage caused by a blood-borne cytokine. Adv Exp Med Biol 1991;305:127–35.

    PubMed  CAS  Google Scholar 

  50. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17–23.

    Article  PubMed  CAS  Google Scholar 

  51. Silliman C, Pitman J, Thurman G, Ambruso D. Neutrophil (PMN) priming agents develop in patients with transfusion related acute lung injury. Blood (Suppl.) 1992; 261a.

    Google Scholar 

  52. Jeter EK, Spivey MA. Noninfectious complications of blood transfusion. Haematology/Oncology Clinics of North American 1995:9:187–204.

    CAS  Google Scholar 

  53. Frewin DB, Jonsson JR, Davis KG, et al. Effect of microfiltration on the histamine levels in stored human blood. Vox Sang 1987; 52:191–94.

    Article  PubMed  CAS  Google Scholar 

  54. Frewin DB, Jonsson JR, Frewin CR, et al. Influence of blood storage time and plasma histamine levels on the pattern of transfusion reactions. Vox Sang 1989;56:243–56.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Kluwer Academic Publishers

About this chapter

Cite this chapter

Heddle, N.M. (1997). Clinical Relevance of Cytokine Levels in Blood Products: Evidence to Correlate with Morbidity. In: Sibinga, C.T.S., Das, P.C., Löwenberg, B. (eds) Cytokines and Growth Factors in Blood Transfusion. Developments in Hematology and Immunology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1137-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1137-9_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8435-2

  • Online ISBN: 978-1-4613-1137-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics